Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain

NCT03477487 is registered in ClinicalTrials.gov with Xalud Therapeutics, Inc. as lead sponsor.

NCT NCT03477487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain
Lead sponsor
Xalud Therapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 8, 2018
Completion date
September 30, 2019
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee